- Investing Ideas
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Diaceutics
Market Cap: UK£123.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
New
DXRX
UK£1.46
7D
15.4%
1Y
6.2%
AstraZeneca
Market Cap: UK£178.4b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£115.00
7D
-11.1%
1Y
2.5%
hVIVO
Market Cap: UK£50.2m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.073
7D
2.8%
1Y
-27.0%